Your browser doesn't support javascript.
loading
Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow­up of 14.4 years.
Kürzel, Sabine; Blaudszun, André-René; Stahl, Lilly; Herbst, Regina; Kroschinsky, Frank; Birkmann, Josef; Hänel, Annette; Schaefer-Eckart, Kerstin; Ehninger, Gerhard; Fiedler, Friedrich; Bornhäuser, Martin; Fricke, Stephan; Hänel, Mathias.
Afiliação
  • Kürzel S; Medical Clinic 5, Klinikum Dresden-Neustadt, Dresden, Germany.
  • Blaudszun AR; Department of GMP Process Development/ATMP Design, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.
  • Stahl L; Department of GMP Process Development/ATMP Design, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.
  • Herbst R; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Flemmingstrasse 1, 09116, Chemnitz, Germany.
  • Kroschinsky F; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU, Dresden, Germany.
  • Birkmann J; Klinikum Nuernberg, Paracelsus Medical Private University, Medical Clinic 5, Nuremberg, Germany.
  • Hänel A; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Flemmingstrasse 1, 09116, Chemnitz, Germany.
  • Schaefer-Eckart K; Klinikum Nuernberg, Paracelsus Medical Private University, Medical Clinic 5, Nuremberg, Germany.
  • Ehninger G; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU, Dresden, Germany.
  • Fiedler F; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Flemmingstrasse 1, 09116, Chemnitz, Germany.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU, Dresden, Germany.
  • Fricke S; Department of GMP Process Development/ATMP Design, Fraunhofer Institute for Cell Therapy and Immunology IZI, Leipzig, Germany.
  • Hänel M; Department of Internal Medicine III, Klinikum Chemnitz gGmbH, Flemmingstrasse 1, 09116, Chemnitz, Germany.
J Cancer Res Clin Oncol ; 149(2): 929-931, 2023 Feb.
Article em En | MEDLINE | ID: mdl-36083312
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: J Cancer Res Clin Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha